HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH
MUNDIPHARMA FOR THE DISTRIBUTION AND LICENCE OF
ANAMORELIN IN NORTHERN EUROPE COUNTRIES
This exclusive agreement strengthens previous alliances with Mundipharma and its network of
independent associated companies in cancer supportive care across multiple territories
worldwide.
Linkedin